Great West Life Assurance CO Kura Oncology, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,836 shares of KURA stock, worth $372,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,836
Previous 6,268
184.56%
Holding current value
$372,415
Previous $134,000
173.88%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$148 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$145 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$121 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$113 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$94.8 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.4B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...